Literature DB >> 19636061

Vascular complications after splenectomy for hematologic disorders.

Shelley E Crary1, George R Buchanan.   

Abstract

The most widely recognized long-term risk of splenectomy is overwhelming bacterial infection. More recently, thrombosis has become appreciated as another potential complication of the procedure. Because of these long-term risks, the indications for and timing of splenectomy are debated in the medical community. Accordingly, the adverse effects and benefits of splenectomy for hematologic disorders and other conditions demand further study. This comprehensive review summarizes the existing literature pertaining to vascular complications after splenectomy for hematologic conditions and attempts to define the potential pathophysiologic mechanisms involved. This complex topic encompasses diverse underlying conditions for which splenectomy is performed, diverse thrombotic complications, and multiple pathophysiologic mechanisms.

Entities:  

Mesh:

Year:  2009        PMID: 19636061      PMCID: PMC2756197          DOI: 10.1182/blood-2009-04-210112

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  139 in total

1.  The role of spleen in suppressing the rheological alterations in circulating blood.

Authors:  O K Baskurt
Journal:  Clin Hemorheol Microcirc       Date:  1999       Impact factor: 2.375

2.  Acute priapism in a patient with unstable hemoglobin Perth and Factor V Leiden under effective oral anticoagulant therapy.

Authors:  E Gyan; S Darre; B Jude; N Cambier; J L Demory; F Bauters; C Rose
Journal:  Hematol J       Date:  2001

3.  Splenectomy: a strong risk factor for pulmonary hypertension in patients with thalassaemia.

Authors:  A Phrommintikul; A Sukonthasarn; R Kanjanavanit; W Nawarawong
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

4.  Delayed pulmonary hypertension following splenectomy for congenital spherocytosis.

Authors:  D L Jardine; A D Laing
Journal:  Intern Med J       Date:  2004-04       Impact factor: 2.048

5.  Delayed adverse vascular events after splenectomy in hereditary spherocytosis.

Authors:  R F Schilling; R E Gangnon; M I Traver
Journal:  J Thromb Haemost       Date:  2008-05-15       Impact factor: 5.824

6.  Spherocytosis, splenectomy, strokes, and heat attacks.

Authors:  R F Schilling
Journal:  Lancet       Date:  1997-12-06       Impact factor: 79.321

7.  Splenectomy and chronic thromboembolic pulmonary hypertension.

Authors:  X Jaïs; V Ioos; C Jardim; O Sitbon; F Parent; A Hamid; E Fadel; P Dartevelle; G Simonneau; M Humbert
Journal:  Thorax       Date:  2005-08-05       Impact factor: 9.139

Review 8.  Leukocytosis and ischemic vascular disease morbidity and mortality: is it time to intervene?

Authors:  Barry S Coller
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-01-20       Impact factor: 8.311

9.  Thromboembolic complications in an asplenic HbE-beta-thalassaemia patient.

Authors:  A van Teunenbroek; F A Wijburg; J W ten Cate; W van den Berg; R S Weening
Journal:  Neth J Med       Date:  1989-10       Impact factor: 1.422

Review 10.  A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major.

Authors:  A Eldor; J Maclouf; F Lellouche; V Ben-Yashar; Y Barenholz; R Durst; E Hy-Am; A Goldfarb; E Rachmilewitz
Journal:  Southeast Asian J Trop Med Public Health       Date:  1993       Impact factor: 0.267

View more
  75 in total

Review 1.  Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters.

Authors:  Lisa J Toltl; Donald M Arnold
Journal:  Br J Haematol       Date:  2010-11-18       Impact factor: 6.998

Review 2.  Anemia, ineffective erythropoiesis, and hepcidin: interacting factors in abnormal iron metabolism leading to iron overload in β-thalassemia.

Authors:  Sara Gardenghi; Robert W Grady; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2010-10-15       Impact factor: 3.722

3.  Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.

Authors:  Bing Li; Ying Jie Ji; Qing Shao; Zhenyu Zhu; Dong Ji; Fan Li; Guofeng Chen
Journal:  Exp Ther Med       Date:  2015-10-23       Impact factor: 2.447

4.  Biomechanics of red blood cells in human spleen and consequences for physiology and disease.

Authors:  Igor V Pivkin; Zhangli Peng; George E Karniadakis; Pierre A Buffet; Ming Dao; Subra Suresh
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

Review 5.  Thalassemia and Moyamoya syndrome: unfurling an intriguing association.

Authors:  Shambaditya Das; Souvik Dubey; Mrinal Acharya; Subhankar Chatterjee; Durjoy Lahiri; Goutam Das; Biman Kanti Ray; Markus Kraemer
Journal:  J Neurol       Date:  2019-08-17       Impact factor: 4.849

6.  Vascular complications after splenectomy for hematologic disorders.

Authors:  Gregory J Kato
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

Review 7.  How I treat autoimmune lymphoproliferative syndrome.

Authors:  V Koneti Rao; João Bosco Oliveira
Journal:  Blood       Date:  2011-09-01       Impact factor: 22.113

Review 8.  Laparoscopic splenectomy: standardized approach.

Authors:  Liane S Feldman
Journal:  World J Surg       Date:  2011-07       Impact factor: 3.352

Review 9.  Pleiotropic effects of intravascular haemolysis on vascular homeostasis.

Authors:  Gregory J Kato; James G Taylor
Journal:  Br J Haematol       Date:  2009-12-01       Impact factor: 6.998

Review 10.  Is it worth investigating splenic function in patients with celiac disease?

Authors:  Antonio Di Sabatino; Laura Brunetti; Gabriella Carnevale Maffè; Paolo Giuffrida; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.